These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12409991)

  • 1. Further evidence for the predictive validity of the unstable elevated exposed plus-maze, a behavioural model of extreme anxiety in rats: differential effects of fluoxetine and chlordiazepoxide.
    Jones N; King SM; Duxon MS
    Behav Pharmacol; 2002 Nov; 13(7):525-35. PubMed ID: 12409991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents.
    Jones N; Duxon MS; King SM
    Psychopharmacology (Berl); 2002 May; 161(3):314-23. PubMed ID: 12021835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze.
    Jones N; Duxon MS; King SM
    Psychopharmacology (Berl); 2002 Nov; 164(2):214-20. PubMed ID: 12404085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test.
    Holmes A; Iles JP; Mayell SJ; Rodgers RJ
    Behav Brain Res; 2001 Aug; 122(2):159-67. PubMed ID: 11334646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexin-1 receptor antagonism fails to reduce anxiety-like behaviour in either plus-maze-naïve or plus-maze-experienced mice.
    Rodgers RJ; Wright FL; Snow NF; Taylor LJ
    Behav Brain Res; 2013 Apr; 243():213-9. PubMed ID: 23333844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free versus forced exposure to an elevated plus-maze: evidence for new behavioral interpretations during test and retest.
    Roy V; Chapillon P; Jeljeli M; Caston J; Belzung C
    Psychopharmacology (Berl); 2009 Mar; 203(1):131-41. PubMed ID: 18998112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure.
    Dawson GR; Crawford SP; Stanhope KJ; Iversen SD; Tricklebank MD
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):570-2. PubMed ID: 7862878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of pseudopregnancy in the rat alters the response to progesterone, chlordiazepoxide, and MK-801 in the elevated plus-maze.
    Bitran D; Solano SM
    Psychopharmacology (Berl); 2005 Jul; 180(3):447-54. PubMed ID: 15700179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escape-related behaviours in an unstable elevated and exposed environment. I. A new behavioural model of extreme anxiety.
    King SM
    Behav Brain Res; 1999 Jan; 98(1):113-26. PubMed ID: 10210528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panic-modulating effects of alprazolam, moclobemide and sumatriptan in the rat elevated T-maze.
    Sant'Ana AB; Weffort LF; de Oliveira Sergio T; Gomes RC; Frias AT; Matthiesen M; Vilela-Costa HH; Yamashita PS; Vasconcelos AT; de Bortoli V; Del-Ben CM; Zangrossi H
    Behav Brain Res; 2016 Dec; 315():115-22. PubMed ID: 27531502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze.
    Holmes A; Rodgers RJ
    Neurosci Biobehav Rev; 1999 Nov; 23(7):971-80. PubMed ID: 10580311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are benzodiazepines really anxiolytic? Evidence from a 3D maze spatial navigation task.
    Ennaceur A; Michalikova S; van Rensburg R; Chazot PL
    Behav Brain Res; 2008 Mar; 188(1):136-53. PubMed ID: 18055029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration.
    Vicente MA; Zangrossi H
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):389-400. PubMed ID: 21733232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting effects of acute and chronic treatment with imipramine and fluoxetine on inhibitory avoidance and escape responses in mice exposed to the elevated T-maze.
    Gomes KS; de Carvalho-Netto EF; Monte KC; Acco B; Nogueira PJ; Nunes-de-Souza RL
    Brain Res Bull; 2009 Mar; 78(6):323-7. PubMed ID: 19047015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.
    Lalonde R; Strazielle C
    Fundam Clin Pharmacol; 2010 Jun; 24(3):365-76. PubMed ID: 19735300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new antiepileptic drug levetiracetam normalises chlordiazepoxide withdrawal-induced anxiety in mice.
    Lamberty Y; Gower AJ; Klitgaard H
    Eur J Pharmacol; 2002 Mar; 439(1-3):101-6. PubMed ID: 11937098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic-like effects of olanzapine, risperidone and fluoxetine in the elevated plus-maze test in rats.
    Rogóż Z; Skuza G
    Pharmacol Rep; 2011; 63(6):1547-52. PubMed ID: 22358103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze test is abolished by previous administration of chlordiazepoxide or buspirone.
    Escarabajal MD; Torres C; Flaherty CF
    Life Sci; 2003 Jul; 73(8):1063-74. PubMed ID: 12818358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlapping and distinct brain regions associated with the anxiolytic effects of chlordiazepoxide and chronic fluoxetine.
    Bechtholt AJ; Valentino RJ; Lucki I
    Neuropsychopharmacology; 2008 Aug; 33(9):2117-30. PubMed ID: 17987061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlordiazepoxide reduces anxiety-like behavior in the adolescent mouse elevated plus maze: A pharmacological validation study.
    Themann A; Rodriguez M; Reyes-Arce J; Iñiguez SD
    Pharmacol Biochem Behav; 2024 Sep; 242():173819. PubMed ID: 38986686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.